Aldeyra Therapeutics Inc (ALDX)
3.94
+0.03
(+0.77%)
USD |
NASDAQ |
Apr 24, 16:00
4.00
+0.06
(+1.52%)
Pre-Market: 08:42
Aldeyra Therapeutics Price to Book Value: 1.937 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.937 |
| April 23, 2024 | 1.922 |
| April 22, 2024 | 1.932 |
| April 19, 2024 | 1.898 |
| April 18, 2024 | 1.957 |
| April 17, 2024 | 1.952 |
| April 16, 2024 | 1.903 |
| April 15, 2024 | 2.045 |
| April 12, 2024 | 2.090 |
| April 11, 2024 | 2.163 |
| April 10, 2024 | 2.090 |
| April 09, 2024 | 2.178 |
| April 08, 2024 | 2.153 |
| April 05, 2024 | 2.320 |
| April 04, 2024 | 2.303 |
| April 03, 2024 | 2.040 |
| April 02, 2024 | 1.745 |
| April 01, 2024 | 1.608 |
| March 28, 2024 | 1.608 |
| March 27, 2024 | 1.514 |
| March 26, 2024 | 1.436 |
| March 25, 2024 | 1.416 |
| March 22, 2024 | 1.426 |
| March 21, 2024 | 1.431 |
| March 20, 2024 | 1.436 |
| Date | Value |
|---|---|
| March 19, 2024 | 1.401 |
| March 18, 2024 | 1.367 |
| March 15, 2024 | 1.372 |
| March 14, 2024 | 1.362 |
| March 13, 2024 | 1.426 |
| March 12, 2024 | 1.477 |
| March 11, 2024 | 1.598 |
| March 08, 2024 | 1.780 |
| March 07, 2024 | 1.893 |
| March 06, 2024 | 1.932 |
| March 05, 2024 | 1.932 |
| March 04, 2024 | 2.011 |
| March 01, 2024 | 2.085 |
| February 29, 2024 | 1.789 |
| February 28, 2024 | 1.823 |
| February 27, 2024 | 1.863 |
| February 26, 2024 | 1.809 |
| February 23, 2024 | 1.725 |
| February 22, 2024 | 1.749 |
| February 21, 2024 | 1.655 |
| February 20, 2024 | 1.700 |
| February 16, 2024 | 1.774 |
| February 15, 2024 | 1.779 |
| February 14, 2024 | 1.680 |
| February 13, 2024 | 1.571 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7073
Minimum
Oct 27 2023
11.28
Maximum
Feb 16 2021
2.956
Average
2.424
Median
Jan 17 2023
Price to Book Value Benchmarks
| AbbVie Inc | 28.61 |
| United Therapeutics Corp | 1.864 |
| Heron Therapeutics Inc | -- |
| Esperion Therapeutics Inc | -- |
| FibroGen Inc | -- |
Price to Book Value Related Metrics
| Price | 3.94 |
| Earnings Yield | -16.24% |
| Market Cap | 232.05M |